The HIF-1α/JMJD1A signaling pathway regulates oxidative stress and inflammation in diabetic vascular injury models, presenting a potential mechanistic target.
No immediate clinical implications in diabetic vasculopathy; leaves open HIF-1α/JMJD1A targeting for mechanistic and translational studies.
These findings provide novel evidence that the HIF-1α/JMJD1A signaling pathway is involved in inflammation and oxidative stress in HUVECs induced by high glucose and hypoxia. Also, this pathway might act as a novel regulator of oxidative stress and inflammatory-related events in response to diabetic vascular injury and thus contribute to the pathological progression of diabetes and vascular disease.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: